期刊文献+

结核性、恶性胸腔积液的鉴别诊断的研究进展 被引量:6

Progress in the Differential Diagnosis of Tuberculous and Malignant Pleural Effusions
下载PDF
导出
摘要 胸腔积液是临床常见的胸膜病变,也是多种疾病的伴随表现。据统计有50多种疾病可直接或间接引起胸腔积液。胸腔积液的病因诊断一直是临床上非常重视的话题,而结核性胸腔积液(TPE)和恶性胸腔积液(MPE)在呼吸内科最为常见,两种疾病的治疗完全不同,故早期诊断及合理治疗对患者的预后起着至关重要的作用。目前临床上有多种实验室指标及检测方法用于两种胸腔积液的鉴别,但各有利弊。随着实验技术及分子生物学的飞速发展,一些新的实验技术及实验指标应运而生。本文旨在对不同实验指标和检测方法对结核性、恶性胸腔积液的鉴别诊断价值进行综述。 Pleural effusion is a common clinical pleural disease,but also accompanied by a variety of diseases.According to statistics,more than 50 kinds of diseases can directly or indirectly cause pleural effusion.The etiological diagnosis of pleural effusion is clinically very important topic,and tuberculous pleural effusion(TPE)and malignant pleural effusion(MPE)is the most common respiratory medicine,the treatment of two diseases are completely different,so early diagnosis and reasonable treatment play a crucial role in the prognosis of patients.Currently there are a variety of clinical laboratory indicators and detection methods for the identification of two pleural effusion,but each has advantages and disadvantages.With the rapid development of experimental technology and molecular biology,some new experimental techniques and experimental indicators came into being.This article aims to summarize the differential diagnostic value of different experimental indicators and detection methods for tuberculous and malignant pleural effusion.
作者 李翔云 李薇 张泽明 LI Xiangyun;LI Wei;ZHANG Zeming(Department of Respiratory,Affiliated Hospital of Hebei University,Baoding Hebei 071000,China;Department of Oncology,Affiliated Hospital of Hebei University,Baoding Hebei 071000,China;Department of Respiratory,Shanghai Pudong New District Zhoupu Hospital,Shanghai 201318,China)
出处 《中国继续医学教育》 2018年第11期109-112,共4页 China Continuing Medical Education
基金 河北省财政厅河北省卫生计生委2017年政府资助临床医学优秀人才培养和基础课题研究项目
关键词 结核性胸腔积液 恶性胸腔积液 鉴别诊断 综述 tuberculous pleural effusion malignant pleural effusion differential diagnosis review
  • 相关文献

参考文献9

二级参考文献94

  • 1张艳梅,付红,张颖.免疫组化在胸膜上皮性恶性肿瘤鉴别诊断中的价值[J].中国肺癌杂志,2007,10(4):320-323. 被引量:8
  • 2林祥伟,黄宇泽,王奕中.结核性与恶性胸腔积液中ADA、CEA及CA-199应用价值探讨[J].放射免疫学杂志,2006,19(4):351-352. 被引量:8
  • 3李静 梅昆.胸水癌胚抗原与铁蛋白检测对恶性胸水的参考价值[J].中华结核和呼吸杂志,1994,17(3):183-183.
  • 4Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA, CA1523, CA1929, CYFRA2121 and TSA assay in pleural effusions [ J]. Lung Cancer, 2001, 31 ( 1 ) :9-16.
  • 5Valdes L, Pose A, San JE, et al. Tuberculous pleural effusions[J]. Eur J Intern Med, 2003, 14(2) :77-88.
  • 6Nakano J,Huang C L,Liu D,et al.Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cel llung cancer[J].Int J Oncol,2005,27(5):1215-1221.
  • 7Abe S,Yoshimura H,Tabara H,et al.Curative resection of gastric cancer:limitation of peritoneal lavage cytology in predicting the outcome[J].J Surg Oncol,1995,59(4):226-229.
  • 8Altieri DC.The molecular basis and potential role of survivin in cancer diagnosis and therapy[J].Trends Mol Med,2001,7(12):542-547.
  • 9Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human Survivin is a direct inhibitor of Caspase -3 and 7[J].Biochemistry,2001,40(4):1117-1123.
  • 10Monzo M,Rosell R,Felip E,et al.A novel anti-apoptosis gene:re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers[J].J Clin Oncol,1999,17 (7):2100-2104.

共引文献69

同被引文献36

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部